期刊文献+

慢性痛风性关节炎患者血清骨保护素及瘦素水平与骨质疏松的相关性 被引量:2

下载PDF
导出
摘要 目的检测慢性痛风性关节炎患者血清骨保护素(OPG)及瘦素(LEP)水平,探讨与骨质疏松(OP)的关系。方法采用双能X线吸收法(DXA)测定慢性痛风性关节炎患者51例(观察组)及健康者50例(对照组)的骨密度,根据骨密度情况将痛风患者分为合并OP组和非OP组,采用ELISA方法测定所有受试者血清0PG及LEP水平,并测定超敏C反应蛋白(hs-CRP)等其它临床指标,分析OPG与LEP的变化及其与骨质疏松的关系。结果慢性痛风性关节炎患者OPG水平较对照组显著降低(P〈0.05),而LEP水平则显著增高(P〈0.05);合并OP组患者CRP、LEP水平显著高于非0P组患者(P〈0.05),而OPG水平则显著下降(P〈0.05)。相关性研究表明慢性痛风性关节炎患者OP严重程度与hs-CRP(r=-0.240,P〈0.01)、LEP(r=-0.351,P〈0.05)水平呈显著负相关性。结论慢性痛风性关节炎患者易出现骨质疏松,患者血清OPG和LEP水平的变化可能与痛风患者骨质疏松的发生密切相关。 Objective To analysis the relationship between serum levels of osteoprotegerin ( OPG ) , leptin ( LEP ) and occurrence of osteoporosis ( OP ) in patients with chronic gouty arthritis. Methods Bone mineral density ( BMD ) of 51 patients with chronic gouty arthritis ( Patient Group ) and 50 healthy volunteers ( Control Group ) were measured through dual-energy X-ray absorptiometry ( DXA ) , 51 patients were divided into OP group and non-OP group according to BMD, serum levels OPG and LEP were examined by ELISA in all subjects, high sensitivity C-raactive protein ( hs-CRP ) and other clinical parameters was collected at the same time. The relationships between OPG, LEP and BMD were also explored. Results The serum level of OPG were significantly decreased in Patient Group compared to Control Group ( P〈0.05 ) , along with a significantly increased level of LEP ( P〈0.01 ) . The patients in OP group had higher levels of serum CRP and LEP but lower levels of OPG compared with non-OP group.Correlation analysis indicated that the levels of CRP ( r=--0.240, P〈0.01 ) and LEP ( r=-0.240, P〈0.01 ) were negative correlated with severity of osteoprorosis in patients with chronic gouty arthritis. Conclusion Patitents with chronic gouty arthritis shows higher incidence of osteoprorosis, the increased level of LEP and decreased level of OPG were correlated with osteoprorosis in gout.
作者 郑雪娜 李敏
出处 《浙江临床医学》 2015年第11期1880-1881,共2页 Zhejiang Clinical Medical Journal
关键词 痛风 骨质疏松 骨保护素 瘦素 Gout Osteoporosis Osteoprotegerin Leptin
  • 相关文献

参考文献8

  • 1Choi HK, Mount DB, Reginato AM, et al. Pathogenesis of gout. Ann Intern Med, 2005, 143: 499-516.
  • 2Horwood NJ,Kartsogiannis V, Quinn JM, et al. Activated T lymphocytes support osteoclast formation in vitro. Biechem Biophys Res Commun, 1999, 265(1):144-150.
  • 3徐建春,毛应德龙,史晓林,吴建民.骨质疏松症的研究进展与展望[J].浙江临床医学,2006,8(1):89-90. 被引量:23
  • 4Yaegashi Y, Nishida J, Oyama K.Gouty tophus of the second metacarpal simulating a malignancy with pathologic fracture. J Hand Surg Am, 2013,38(1):208-209.
  • 5Kong YY, Feige U, SaresiI,et al. Activated T cellegulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand. Nature, 1999, 402(6759):304-309.
  • 6Stofkova A. Leptin and adiponectin: from energy and metabolic dysbalance to inflammation and autoimmunity.Endocr Regul,2009,43(4):157-168.
  • 7Burguera B, Hofbauer LC, Thomas T, et al.Leptin reduces ovariectorny- induced bone loss in rats.Endocrinology,2001,142(8):3546-3553.
  • 8吴文华,肖雨龙,杨晓妹.阿仑膦酸钠对连续血液透析骨质疏松患者骨密度的影响[J].海南医学,2013,24(2):184-186. 被引量:8

二级参考文献38

  • 1刘浩,程凯,王仲,陈爱萍.强骨胶囊配合运动疗法治疗原发性骨质疏松症[J].中国康复,2005,20(2):107-107. 被引量:4
  • 2李裕明,张众志,邓秀玲,王琳芳,陈璐璐.利塞膦酸钠治疗绝经后骨质疏松症的疗效及安全性[J].中国骨质疏松杂志,2006,12(1):62-65. 被引量:8
  • 3Ro nbinson. Ostcoclasts and transforming growth factor be estrogen medi atedesform specific regulation of production. Endorinology , 1996, 137(2):615.
  • 4Abbott TA, Mueha L, Manfredonia D, et al. Efficient patient identification strategies for women with osteoporosis. J Clin Densitom, 1999,2(3) :223 - 230.
  • 5Laczo P, Krpan D, krvavica A, et al. Bone histology in postmenopausa osteoporosis variations in celly activity. Act MED Croatica, 2004, 58 ( 1 ) : 5-11.
  • 6Wallach S, Rousseau G, Martin L. Effects of calcitonin on animal and in vitro models of skeletal metabolism. Bone, 1999,25(5) :509 - 516.
  • 7Beavans, Prentia A. Polymorphism of the collagen type Ⅰ algene and ethnic differences in hipfraeture rates. N Engl J Med, 1998,339:351 - 352.
  • 8Charles P, Moseklcle L. Assessment of bone remodeling using biochemical indicators of type Ⅰ collagen synthesis and degredation: Relation to Calcium Kinetics. Bone Miner, 1994,24:81 - 94,.
  • 9Robins SP, Woiteg H, Hisley R, et al. Direct enzyme linked immunoassay for urinary deoxypyridinoline as aspecfic marker for measuring bone risorption. J Bone Miner Res, 1994,9(10) : B1643 - 1649.
  • 10Swaminathan R. biochemical makers of bone turnout. Clin Chim Acta,2001,13:95 - 105.

共引文献29

同被引文献24

引证文献2

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部